Hannah Moyer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Randomized Controlled Trial

Top Venues

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah Moyer, Robyn Mellett, Karine Vigneault, Maya McKeown, Jason Karlawish, Erika Augustine, Lon Schneider, Jonathan Kimmelman
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development. Neurology 103 (1) (2024)
Hannah Moyer, Robyn Mellett, Karine Vigneault, Maya McKeown, Jason Karlawish, Erika Augustine, Lon Schneider, Jonathan Kimmelman
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development. Neurology 103 (1) (2024)
Hannah Moyer, Robyn Mellett, Karine Vigneault, Maya McKeown, Jason Karlawish, Erika Augustine, Lon Schneider, Jonathan Kimmelman
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development. Neurology 103 (1) (2024)
Hannah Moyer, Robyn Mellett, Karine Vigneault, Maya McKeown, Jason Karlawish, Erika Augustine, Lon Schneider, Jonathan Kimmelman
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development. Neurology 103 (1) (2024)
Renata Iskander, Hannah Moyer, Dean A Fergusson, Sean McGrath, Andrea Benedetti, Jonathan Kimmelman
The Benefits and Risks of Receiving Investigational Solid Tumor Drugs in Randomized Trials : A Systematic Review and Meta-analysis. Annals of internal medicine (2024)
Renata Iskander, Hannah Moyer, Dean A Fergusson, Sean McGrath, Andrea Benedetti, Jonathan Kimmelman
The Benefits and Risks of Receiving Investigational Solid Tumor Drugs in Randomized Trials : A Systematic Review and Meta-analysis. Annals of internal medicine 177 (6) (2024)
Renata Iskander, Hannah Moyer, Dean A Fergusson, Sean McGrath, Andrea Benedetti, Jonathan Kimmelman
The Benefits and Risks of Receiving Investigational Solid Tumor Drugs in Randomized Trials : A Systematic Review and Meta-analysis. Annals of internal medicine 177 (6) (2024)
Nora Hutchinson, Hannah Moyer, Deborah A Zarin, Jonathan Kimmelman
The proportion of randomized controlled trials that inform clinical practice. eLife 11 (2022)